Overview
Jong-sun Kang practices in Suwon, Republic of Korea. Kang is rated as an Advanced expert by MediFind in the treatment of Long QT Syndrome 3. Their top areas of expertise are Muscle Atrophy, Long QT Syndrome 3, Rhabdomyosarcoma, and Doxorubicin-Induced Cardiomyopathy.
Their clinical research consists of co-authoring 97 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Long QT Syndrome 3.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Long QT Syndrome 3Kang isAdvanced. Learn about Long QT Syndrome 3.
- Muscle AtrophyKang isAdvanced. Learn about Muscle Atrophy.
- Experienced
- Acute Coronary SyndromeKang isExperienced. Learn about Acute Coronary Syndrome.
- Cardiomyopathy Due to Anthracyclines
- Cramp-Fasciculation Syndrome
- Doxorubicin-Induced Cardiomyopathy
- RhabdomyosarcomaKang isExperienced. Learn about Rhabdomyosarcoma.